Olgu Sunumu
BibTex RIS Kaynak Göster

Yıl 2021, Cilt: 38 Sayı: 1, 47 - 50, 26.01.2021

Ayhan Karaköse Çağatay Arslan Erkan Şahin Ragıp Ortaç

Öz

Kaynakça

  • Walenkamp, A.M., Sonke, G.S., Sleijfer, D.T., 2009. Clinical and therapeutic aspects of extrapulmonary small cell carcinoma.Cancer Treat Rev. May;35(3):228-36. doi: 10.1016/j.ctrv.2008.10.007. Epub 2008 Dec 9.
  • Demirtaş, A., Şahin, N., Öztürk, F., Akınsal, E.C., Demirtaş, T., Ekmekcioğlu, O., Tatlışen, A., 2013. Small Cell Prostate Carcinoma: A Case Report and Review of the Literature. Case Rep Urol. 2013: 387931doi: 10.1155/2013/387931
  • Weprin, S., Yonover, P., 2017. Small Cell Carcinoma of the Prostate: A Case Report and Brief Review of the Literature.Urol Case Rep. Apr 26;13:61-62. doi: 10.1016/j.eucr.2016.10.010. eCollection 2017 Jul.
  • Wenk, R.E., Bhagavan, B.S., Levy, R., Miller, D., Weisburger, W., 1977. Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia.Cancer. Aug;40(2):773-8.
  • Spiess, P.E., Pettaway, C.A., Vakar-Lopez, F., Kassouf, W., Wang, X., Busby, J.E., Do, K.A., Davuluri, R., Tannir, N.M., 2007. Treatment outcomes of small cell carcinoma of the prostate: a single-center study. Cancer. Oct 15;110(8):1729-37.
  • Petraki, C., Vaslamatzis, M., Petraki, K., Revelos, K., Alevizopoulos, N., Papanastasiou, P., Gregorakis, A., 2005. Prostatecancer with small-cell morphology: an immunophenotypic subdivision. Scand J Urol Nephrol 39:455–463.
  • Palmgren, J.S., Karavadia, S.S., Wakefield, M.R., 2007. Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol 34:22–29.
  • Papandreou, C.N., Daliani, D.D., Thall, P.F., Tu, S.M., Wang, X., Reyes, A., Troncoso, P., Logothetis, C.J., 2002. Results of aphase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 20:3072–3080.
  • Erasmus, C.E., Verhagen, W.I., Wauters, C.A., vanLindert, E.J., 2002. Brain metastasis from prostate small cell carcinoma: Not to be neglected. Can J Neurol Sci. 29:375.
  • Deorah, S., Rao, M.B., Raman, R., Gaitonde, K., Donovan, J.F., 2012. Survival of patients with small cell carcinoma of the prostate during 1973-2003: A population-based study. BJU Int. 109:824.
  • Capizzello, A., Peponi, E., Simou, N., Ntaskagiannis, D., Tasiou, I., Kamina, S., Tsekeris, P., 2001. Pure small cell carcinoma of the prostate: a case report and literature review. Case Rep Oncol. Feb 16;4(1):88-95. doi: 10.1159/000324717.
  • Asmis, T.R., Reaume, M.N., Dahrouge, S., Malone, S., 2006. Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center. BJU Int. Apr;97(4):711-5.
  • Hindson, D.A., Knight, L.L., Ocker, J.M., 1985. Small-cell carcinoma of prostate. Transient complete remission with chemotherapy. Urology. Aug;26(2):182-4.
  • Brammer, J.E., Lulla, P., Lynch, G.R., 2011.Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate. Int J ClinOncol. Dec;16(6):722-5. doi: 10.1007/s10147-011-0198-2. Epub 2011 Feb 24.

Small cell prostate cancer: A very rare entity

Yıl 2021, Cilt: 38 Sayı: 1, 47 - 50, 26.01.2021

Ayhan Karaköse Çağatay Arslan Erkan Şahin Ragıp Ortaç

Öz

Small cell prostate cancer which is associated with a high disease specific mortality is a rare disorder accounting for less than 1% of all prostate cancers. We present here a case of 64 years old male patient presented with lower urinary tract symptoms. The prostate needle biopsy result was reported as prostate adenocarcinoma (predominant component small cell carcinoma) Gleason 5 + 3=8 (eight). Chemotherapy and radiotherapy were planned. The patient was asymptomatic 8 months after treatment. He died 13 months after initial diagnosis because of the metastatic lesions.

Anahtar Kelimeler

Small cell carcinoma Prostate cancer Neuroendocrine differentiation

Kaynakça

  • Walenkamp, A.M., Sonke, G.S., Sleijfer, D.T., 2009. Clinical and therapeutic aspects of extrapulmonary small cell carcinoma.Cancer Treat Rev. May;35(3):228-36. doi: 10.1016/j.ctrv.2008.10.007. Epub 2008 Dec 9.
  • Demirtaş, A., Şahin, N., Öztürk, F., Akınsal, E.C., Demirtaş, T., Ekmekcioğlu, O., Tatlışen, A., 2013. Small Cell Prostate Carcinoma: A Case Report and Review of the Literature. Case Rep Urol. 2013: 387931doi: 10.1155/2013/387931
  • Weprin, S., Yonover, P., 2017. Small Cell Carcinoma of the Prostate: A Case Report and Brief Review of the Literature.Urol Case Rep. Apr 26;13:61-62. doi: 10.1016/j.eucr.2016.10.010. eCollection 2017 Jul.
  • Wenk, R.E., Bhagavan, B.S., Levy, R., Miller, D., Weisburger, W., 1977. Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia.Cancer. Aug;40(2):773-8.
  • Spiess, P.E., Pettaway, C.A., Vakar-Lopez, F., Kassouf, W., Wang, X., Busby, J.E., Do, K.A., Davuluri, R., Tannir, N.M., 2007. Treatment outcomes of small cell carcinoma of the prostate: a single-center study. Cancer. Oct 15;110(8):1729-37.
  • Petraki, C., Vaslamatzis, M., Petraki, K., Revelos, K., Alevizopoulos, N., Papanastasiou, P., Gregorakis, A., 2005. Prostatecancer with small-cell morphology: an immunophenotypic subdivision. Scand J Urol Nephrol 39:455–463.
  • Palmgren, J.S., Karavadia, S.S., Wakefield, M.R., 2007. Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol 34:22–29.
  • Papandreou, C.N., Daliani, D.D., Thall, P.F., Tu, S.M., Wang, X., Reyes, A., Troncoso, P., Logothetis, C.J., 2002. Results of aphase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 20:3072–3080.
  • Erasmus, C.E., Verhagen, W.I., Wauters, C.A., vanLindert, E.J., 2002. Brain metastasis from prostate small cell carcinoma: Not to be neglected. Can J Neurol Sci. 29:375.
  • Deorah, S., Rao, M.B., Raman, R., Gaitonde, K., Donovan, J.F., 2012. Survival of patients with small cell carcinoma of the prostate during 1973-2003: A population-based study. BJU Int. 109:824.
  • Capizzello, A., Peponi, E., Simou, N., Ntaskagiannis, D., Tasiou, I., Kamina, S., Tsekeris, P., 2001. Pure small cell carcinoma of the prostate: a case report and literature review. Case Rep Oncol. Feb 16;4(1):88-95. doi: 10.1159/000324717.
  • Asmis, T.R., Reaume, M.N., Dahrouge, S., Malone, S., 2006. Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center. BJU Int. Apr;97(4):711-5.
  • Hindson, D.A., Knight, L.L., Ocker, J.M., 1985. Small-cell carcinoma of prostate. Transient complete remission with chemotherapy. Urology. Aug;26(2):182-4.
  • Brammer, J.E., Lulla, P., Lynch, G.R., 2011.Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate. Int J ClinOncol. Dec;16(6):722-5. doi: 10.1007/s10147-011-0198-2. Epub 2011 Feb 24.
Toplam 14 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Case Report
Yazarlar

Ayhan Karaköse

Çağatay Arslan

Erkan Şahin

Ragıp Ortaç

Yayımlanma Tarihi 26 Ocak 2021
Gönderilme Tarihi 20 Ocak 2020
Kabul Tarihi 12 Ekim 2020
Yayımlandığı Sayı Yıl 2021 Cilt: 38 Sayı: 1

Kaynak Göster

APA Karaköse, A., Arslan, Ç., Şahin, E., Ortaç, R. (2021). Small cell prostate cancer: A very rare entity. Journal of Experimental and Clinical Medicine, 38(1), 47-50.
AMA Karaköse A, Arslan Ç, Şahin E, Ortaç R. Small cell prostate cancer: A very rare entity. J. Exp. Clin. Med. Ocak 2021;38(1):47-50.
Chicago Karaköse, Ayhan, Çağatay Arslan, Erkan Şahin, ve Ragıp Ortaç. “Small Cell Prostate Cancer: A Very Rare Entity”. Journal of Experimental and Clinical Medicine 38, sy. 1 (Ocak 2021): 47-50.
EndNote Karaköse A, Arslan Ç, Şahin E, Ortaç R (01 Ocak 2021) Small cell prostate cancer: A very rare entity. Journal of Experimental and Clinical Medicine 38 1 47–50.
IEEE A. Karaköse, Ç. Arslan, E. Şahin, ve R. Ortaç, “Small cell prostate cancer: A very rare entity”, J. Exp. Clin. Med., c. 38, sy. 1, ss. 47–50, 2021.
ISNAD Karaköse, Ayhan vd. “Small Cell Prostate Cancer: A Very Rare Entity”. Journal of Experimental and Clinical Medicine 38/1 (Ocak 2021), 47-50.
JAMA Karaköse A, Arslan Ç, Şahin E, Ortaç R. Small cell prostate cancer: A very rare entity. J. Exp. Clin. Med. 2021;38:47–50.
MLA Karaköse, Ayhan vd. “Small Cell Prostate Cancer: A Very Rare Entity”. Journal of Experimental and Clinical Medicine, c. 38, sy. 1, 2021, ss. 47-50.
Vancouver Karaköse A, Arslan Ç, Şahin E, Ortaç R. Small cell prostate cancer: A very rare entity. J. Exp. Clin. Med. 2021;38(1):47-50.
 Kapak Resmi İndir

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.